Healthy Volunteers
- All
- News
- Videos
-
World's First Trial With Voluntary Covid Exposure Found Safe In Young Adults: Study
The world's first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.
-
UK Researchers Aim To Infect Healthy Volunteers To Study Covid Exposure
British researchers on Tuesday said they hope to expose healthy volunteers to the virus that causes Covid-19 in a groundbreaking study to discover the amount needed for people to become infected.
-
5 Key Takeaways From Monday's Data On Experimental Coronavirus Vaccines
Two potential vaccines to protect against the novel coronavirus - one from Oxford University and AstraZeneca Plc and the other from China's CanSino Biologics - induced immune responses in healthy volunteers without causing dangerous side effects, according to studies published on Monday in The Lancet.
-
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
-
AIIMS Panel Allows Human Trial Of India's First Coronavirus Vaccine
The AIIMS Ethics Committee on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.
-
First Volunteer Given UK's Imperial College COVID-19 Vaccine
The first healthy volunteer has now received a coronavirus vaccine developed by Imperial College London researchers, the team behind the project said on Tuesday.
-
This Antibiotic Drug May Disrupt the Formation of Fears and Negative Thoughts
The study was conducted on 76 healthy volunteers who were divided two groups - one that received placebo while the other was given doxycycline.
-
Virtual Reality Therapy Could Reduce Depression Symptoms
The therapy, previously tested by healthy volunteers, was used by 15 depression patients aged 23-61.
-
Experimental HIV Vaccine Goes to Human Trial
The vaccine, made by Johnson & Johnson, is being trialled on 400 healthy volunteers in the US, East Africa, South Africa and Thailand.
-
Broccoli Helpful in Preventing Oral Cancer: Study
A new therapy containing broccoli sprout extract has been found to protect not only mice against oral cancer but also has been found to be tolerable in a small group of healthy human volunteers, says a new study.
-
2 Leading Ebola Vaccines Appear Safe, Further Tests Starting
The World Health Organization (WHO) says the two leading Ebola vaccines appear safe and will soon be tested in healthy volunteers in West Africa.
-
Ebola Vaccine from Glaxo Passes Early Safety Test
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
-
Canadian Ebola Vaccine to be Tested in Europe, Gabon, Kenya
Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust.
-
World's First Trial With Voluntary Covid Exposure Found Safe In Young Adults: Study
The world's first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday.
-
UK Researchers Aim To Infect Healthy Volunteers To Study Covid Exposure
British researchers on Tuesday said they hope to expose healthy volunteers to the virus that causes Covid-19 in a groundbreaking study to discover the amount needed for people to become infected.
-
5 Key Takeaways From Monday's Data On Experimental Coronavirus Vaccines
Two potential vaccines to protect against the novel coronavirus - one from Oxford University and AstraZeneca Plc and the other from China's CanSino Biologics - induced immune responses in healthy volunteers without causing dangerous side effects, according to studies published on Monday in The Lancet.
-
Oxford COVID-19 Vaccine Shows Promise In Early Testing: Study
An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.
-
AIIMS Panel Allows Human Trial Of India's First Coronavirus Vaccine
The AIIMS Ethics Committee on Saturday gave its nod for a human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin following which the premier hospital is likely to begin the exercise by enrolling healthy volunteers from Monday.
-
First Volunteer Given UK's Imperial College COVID-19 Vaccine
The first healthy volunteer has now received a coronavirus vaccine developed by Imperial College London researchers, the team behind the project said on Tuesday.
-
This Antibiotic Drug May Disrupt the Formation of Fears and Negative Thoughts
The study was conducted on 76 healthy volunteers who were divided two groups - one that received placebo while the other was given doxycycline.
-
Virtual Reality Therapy Could Reduce Depression Symptoms
The therapy, previously tested by healthy volunteers, was used by 15 depression patients aged 23-61.
-
Experimental HIV Vaccine Goes to Human Trial
The vaccine, made by Johnson & Johnson, is being trialled on 400 healthy volunteers in the US, East Africa, South Africa and Thailand.
-
Broccoli Helpful in Preventing Oral Cancer: Study
A new therapy containing broccoli sprout extract has been found to protect not only mice against oral cancer but also has been found to be tolerable in a small group of healthy human volunteers, says a new study.
-
2 Leading Ebola Vaccines Appear Safe, Further Tests Starting
The World Health Organization (WHO) says the two leading Ebola vaccines appear safe and will soon be tested in healthy volunteers in West Africa.
-
Ebola Vaccine from Glaxo Passes Early Safety Test
An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.
-
Canadian Ebola Vaccine to be Tested in Europe, Gabon, Kenya
Trials of an experimental vaccine developed by the Canadian government and licensed to NewLink Genetics will begin swiftly in healthy volunteers in Europe, Gabon and Kenya, under a programme with funding from the Wellcome Trust.
